Kathleen Colleran, MD
Endocrinology, Diabetes & Metabolism · Albuquerque, NMNPI 1659386118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in NM, where the typical reported total is $1,943.
Across 103 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$318
- Lilly USA, LLC$201
- Boehringer Ingelheim$144
- Amgen$134
- Sanofi-aventis U.S. LLC$99
- Tandem Diabetes Care, Inc.$99
- plus $947 from 21 others
What the payments were for
- Food & beverage$1,89598%
- Education$482%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $318 |
| Lilly USA, LLC | 15 | $201 |
| Boehringer Ingelheim | 8 | $144 |
| Amgen | 8 | $134 |
| Sanofi-aventis U.S. LLC | 6 | $99 |
| Tandem Diabetes Care, Inc. | 4 | $99 |
| Insulet Corporation | 3 | $90 |
| Corcept Therapeutics | 4 | $81 |
| Neurocrine Biosciences, Inc. | 2 | $76 |
| Dexcom, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Organon | 1 | $63 |
| AstraZeneca | 4 | $54 |
| Sunovion Pharmaceuticals Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| BETA Bionics, Inc. | 2 | $49 |
| Medtronic(2 entities) | 3 | $48 |
| Merck | 3 | $44 |
| AbbVie | 2 | $36 |
| Johnson & Johnson | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Abbott | 1 | $17 |
| Aegerion Pharmaceuticals, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$1,943 in reported general payments places this provider in the 50th percentile of 42 endocrinology, diabetes & metabolism providers in New Mexico.
See all endocrinology, diabetes & metabolism providers in New Mexico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Albuquerque
- Robert FerraroAlbuquerque$101K
- Rina Patel TrujilloAlbuquerque$100K
- Jeremy GleesonAlbuquerque$46K
- David SchadeAlbuquerque$16K
- Mansi MehtaAlbuquerque$15K
- Matthew BouchonvilleAlbuquerque$7K
- Teodor DuroAlbuquerque$6K
- Ivan PinonAlbuquerque$5K
- Namrata JannareddyAlbuquerque$4K
- Anita Sloan-GarciaAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.